feed,title,long_url,short_url
MarketWatch,UPDATE: Moderna shares soar premarket after COVID-19 vaccine candidate achieves 94.5% efficacy in Phase 3 trial,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/-JlL1ibem1o/story.aspx,https://on.mktw.net/3f2lsR0
